| |
|
|
|
Avadel Pharmaceuticals Plc  
|
|
5.17 -0.19 (-0.04%) |
10-20 16:00 |
|
Open: |
5.39 |
Pre close: |
5.36 |
Target:
|
6.84
|
|
High: |
5.4 |
Low: |
5.045 |
Resistance:
|
5.86
6.49
|
|
Volume: |
413,198 |
Market Cap: |
301M |
Support:
|
4.83
4.02
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.34
 |
MACD |
MACD(12,26):
|
-0.22 |
|
MA(20): |
5.32 |
Signal(12,26,9): |
-0.27  |
|
MA(100): |
7.27 |
Stochastic Oscillator |
%K(14,3):
|
37.74 |
|
MA(250): |
7.40 |
%D(3): |
45.48 |
|
Average Volume(K) |
3-Month: |
83200
|
52-Week |
High:
|
13.49 |
|
10-Days: |
32588 |
Low: |
3.73 |
|
RSI |
RSI(14):
|
38.52 |
Change(%): |
27.0 |
|
Financials, Statistics and Valuation |
|
EPS |
0.430 |
Return on Equity (ttm) |
22.4 |
Shares Out. (M) |
58.22 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-4.2 |
Shares Float (M) |
35.18 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.13 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-42.5 |
% Held by Institutions |
39.87 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
0.809 |
Shares Short (K) |
6330 |
|
Book Value (p.s.) |
3.130 |
EBITDA (p.s.) |
-0.253 |
P/E |
11.81 |
|
Sales Per Share |
0.817 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.62 |
|
Profit Margin |
38.70 |
Operating Cash Flow
(M) |
-35.09 |
P/S |
6.22 |
|
Operating Margin |
-35.97 |
Levered Free Cash Flow
(M) |
-34.91 |
P/CF |
-8.43 |
|
|
|
|
|
|
